Exodus Point Capital Management, LP Rocket Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 242,184 shares of RCKT stock, worth $738,661. This represents 0.01% of its overall portfolio holdings.
Number of Shares
242,184
Previous 165,037
46.75%
Holding current value
$738,661
Previous $404,000
95.3%
% of portfolio
0.01%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RCKT
# of Institutions
195Shares Held
96.5MCall Options Held
563KPut Options Held
418K-
Rtw Investments, LP New York, NY17.7MShares$53.9 Million0.77% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.47MShares$25.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.9 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.9MShares$11.9 Million2.3% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $231M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...